Please try another search
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. The company is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with relapsed and refractory leukemia and lymphoid malignancies, as well as solid tumors and non-Hodgkin lymphoma; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat advanced or metastatic solid tumors. Its product candidates also include VIP943 in Phase 1 clinical trials for the treatment of relapsed/refractory acute myeloid leukemia, myelodysplastic syndrome, and B-cell acute lymphoblastic leukemia; and VIP924 in preclinical studies for the treatment of B-cell malignancies. Vincerx Pharma, Inc. was founded in 2019 and is based in Palo Alto, California.
Name | Age | Since | Title |
---|---|---|---|
Laura I. Bushnell | 54 | 2020 | Independent Director |
Francisco D. Salva | 52 | 2020 | Independent Director |
Howard A. Burris | - | 2021 | Member of Scientific Advisory Board |
Brian J. Druker | 67 | 2020 | Independent Director |
John H. Lee | 55 | 2020 | Independent Director |
John C. Byrd | - | 2021 | Founder & Chairman of Scientific Advisory Board |
Anthony W. Tolcher | - | 2021 | Member of Scientific Advisory Board |
Ruth E. Stevens | 64 | 2021 | Independent Director |
Andre Goy | - | 2021 | Member of Scientific Advisory Board |
Apostolia Tsimberidou | - | 2024 | Member of Scientific Advisory Board |
Naval G. Daver | - | 2024 | Member of Scientific Advisory Board |
Ian W. Flinn | - | 2021 | Member of Scientific Advisory Board |
Alice Mims | - | 2024 | Member of Scientific Advisory Board |
Marina Konopleva | - | 2024 | Member of Scientific Advisory Board |
Uma Borate | - | 2024 | Member of Scientific Advisory Board |
Amer Zeidan | - | 2024 | Member of Scientific Advisory Board |
Raquel E. Izumi | 54 | 2020 | Co-Founder, President, COO, Secretary & Director |
Ahmed M. Hamdy | 59 | 2020 | Co-Founder, Chairman & CEO |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review